2026 Artemetrx State of Specialty Spend and Trend Report
PSG announces the results of the industry’s go-to report on specialty drug spend and trend. With specialty drug costs remaining a top concern…
Read Post
Insights
Categories
Topics
Categories
Topics
Seize the Day: 4 Reasons to Pursue a PBM Procurement in 2019
The prescription drug market is changing yet again, creating an ideal opportunity for plan sponsors to evaluate vendor options for pharmacy benefit management (PBM).
Read Post
Highlights from the 2019 PBMI Trends in Specialty Drug Benefits Report: Specialty Drug Benefits by the Numbers
For the last eight years, PSG’s Pharmacy Benefit Management Institute (PBMI) has produced original research focused on specialty drug benefit designs used by employers,…
Read Post
What You Need to Know About The Drug Rebate Economy
Drug rebates are big business. According to life sciences analytics firm IQVIA, pharmaceutical manufacturers offered $153 billion in rebates and discounts in 2017. That’s…
Read Post
PSG Analysis: Inflation Trends for Some Prescription Drugs 4X Higher than that of the National Consumer Price Index
Rising prescription drug costs are a major concern in the United States, especially the effect these increases are having on individual patients who are…
Read Post
PSG Position: Trump Administration Rebate Proposal
On January 31, the Trump Administration released a proposal that would require pharmacy benefit managers (PBMs) and insurers to pass through 100% of Medicare rebates…
Read Post
Identifying and Knowing Your High-Cost Members: How to Manage Your Specialty Drug Spend
Controlling specialty drug costs and trends takes constant and careful vigilance. Yet many plan sponsors lack the tools or expertise to monitor integrated member…
Read Post
The Medical Mindset:How PSG Pharmacists Take A Clinical Approach to Managing Spend and Ensuring Member Health
The United States could face a serious shortage of both primary and specialty care physicians by 2030—up to 120,000, according to research from the Association…
Read Post
How to Remedy the Dangers of Prescription Fraud, Waste, and Abuse
Imagine being prescribed a high-cost medication by a doctor you’ve never met and who has never reviewed your medical records. Sounds a bit far-fetched,…
Read Post
PSG Helps Payers Identify and Mitigate Paying for Excessive Quantities on Medical-Benefit Specialty Drug Claims
Specialty drug spend is a constant challenge for nearly all plan sponsors. One significant problem is managing high quantities on claims for specialty drugs…
Read Post
How PSG Fights Against Specialty Drug Price Gouging for Plan Members
Price gouging by pharmaceutical companies is an all-too-common problem that makes health plans and their members pay outrageous prices for previously affordable drugs. Perhaps…
Read Post
Prior Authorizations: A Health Plan’s Secret Tool to Better Patient Care and Lower Specialty Drug Spend
Prior authorizations (PA) have long been a bone of contention between healthcare providers and health plans. Physicians typically dislike them; in fact, 92% of…
Read Post